跳至主要内容
临床试验/NCT01252888
NCT01252888已完成4 期

A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two Trabecular Micro-bypass Stents

Glaukos Corporation2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
39
试验地点
2
主要终点
mean diurnal IOP reduction of greater than or equal to 20% at Month 12 vs baseline

研究概览

简要总结

The purpose of this study is to assess efficacy and safety of two iStents for the reduction of intraocular pressure associated with primary open-angle glaucoma.

详细描述

This study evaluates the safety and efficacy of two iStents implanted in primary open-angle glaucoma subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with primary open-angle glaucoma (POAG)
  • Subjects on two topical hypotensive medications

排除标准

  • Traumatic, uveitic, neovascular, or angle closure glaucoma
  • Fellow eye already enrolled

结局指标

主要结局

mean diurnal IOP reduction of greater than or equal to 20% at Month 12 vs baseline

时间窗: 12 months

次要结局

  • Mean diurnal IOP < 18 mmHg at month 12(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验